Objectives:

  1. Discuss the prevalence and potential risks with supplement and cannabis use by patients with cancer​
  2. Identify common resources to screen supplements for potential treatment interactions​
  3. identify commonly reported supplements and potential interactions with chemotherapy or targeted therapy​
  4. Outline considerations for cannabidiol (CBD) or tetrahydrocannabinol (THC) use in patients with cancer
  5. Explain the oncology pharmacist approach to navigating supplement use in patients with cancer

Zoom Info:

Join from a PC, Mac, iPad, iPhone or Android device: Please click this URL to join. Passcode: Grand https://uwmadison.zoom.us/s/93795409378?pwd=SWRzR1R6cE1HN0dTM2lRbmQvV1NMdz09

Or One tap mobile: +13126266799,,93795409378# US (Chicago); +16469313860,,93795409378# US

Or join by phone: Dial(for higher quality, dial a number based on your current location). Webinar ID: 937 9540 9378

Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East)

  • Webinar ID: 937 9540 9378
  • Passcode: 864581

 SIP: [email protected]; Passcode: 864581

Session date: 
03/22/2023 - 8:00am to 9:00am CDT
Location: 
In-person and Virtually
750 Highland Avenue (HSLC)
HSLC 1306
Madison, WI 53705
United States
See map: Google Maps
  • 1.00 AAPA Category 1 CME
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 ACPE Contact Hours - Pharmacist Technician
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dr. Lindsey Jung
Dr. Elizabeth Dow-Hillgartner